Neuraptive Therapeutics Announces First Patient Enrolled in a Phase 2 Trial of NTX-001 for the Prevention of Facial Paralysis and Provides Update on the Phase 2 Study of NTX-001 in Peripheral Nerve Injuries due to Trauma
Business Wire India – Facial Paralysis Prevention study initiated and first patient enrolled evaluating the safety and efficacy of NTX-001 following facial nerve surgery – Ongoing Trauma Phase 2 study…